Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Doximity, Inc. Class A Common Stock (NY:DOCS)

61.69 +2.38 (+4.01%)
Official Closing Price Updated: 5:00 PM EDT, Jul 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Doximity, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Wall Street Stays Cautious To Close Out A Big Week, Meme Rally Resumes: Analyst Warns Investors 'Not To Sprint On The Victory Lap'
U.S. stocks are poised for a cautious start on Friday as concerns about rising interest rates return. Traders are waiting for a significant catalyst to propel the market higher after its recent record... 
Via Benzinga
Applied Materials, RBC Bearings And 3 Stocks To Watch Heading Into Friday
Via Benzinga
DOCS Stock Earnings: Doximity Beats EPS, Beats Revenue for Q4 2024
DOCS stock results show that Doximity beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024. 
Via InvestorPlace
NYSE:DOCS is showing decent growth, but is still valued reasonably.
Looking for growth without the hefty price tag? Consider DOXIMITY INC-CLASS A (NYSE:DOCS). 
Via Chartmill
NYSE:DOCS qualifies as a high growth stock and is consolidating.
DOXIMITY INC-CLASS A (NYSE:DOCS)—A High-Growth Stock Gearing Up for Its Next Upward Move. 
Via Chartmill
6 Analysts Assess Doximity: What You Need To Know
Via Benzinga
NYSE:DOCS—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
Via Chartmill
Doximity Stock Jumps 10% On Q4 Earnings: What You Need To Know
Doximity's fourth-quarter revenue increased 6% year-over-year to $118.1 million, which beat the consensus estimate of $116.4 million, according to Benzinga Pro. The company reported adjusted earnings... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
2 No-Brainer Growth Stocks Down 29% and 22% to Buy Hand Over Fist Right Now
These businesses are generating strong momentum, despite what share prices might indicate. 
Via The Motley Fool
For those who appreciate growth without the sticker shock, NYSE:DOCS is worth considering.
DOXIMITY INC-CLASS A (NYSE:DOCS) stands out as a growth opportunity that won't break the bank. 
Via Chartmill
6 Analysts Assess Doximity: What You Need To Know
Via Benzinga
NYSE:DOCS, a growth stock which is not overvalued.
Investors should take note ofDOXIMITY INC-CLASS A (NYSE:DOCS), a growth stock that remains attractively priced. 
Via Chartmill
What 6 Analyst Ratings Have To Say About Doximity
Via Benzinga
NYSE:DOCS—A High-Growth Stock Gearing Up for Its Next Upward Move.
Why DOXIMITY INC-CLASS A (NYSE:DOCS) Is a Promising High-Growth Stock in the Midst of Consolidation. 
Via Chartmill
NYSE:DOCS stands out as a growth opportunity that won't break the bank.
Investors seeking growth at a reasonable cost should explore NYSE:DOCS. 
Via Chartmill
HIMS Stock Breaks Out On Powerful Turnaround Quarter
"In 2024, we expect to eclipse $1 billion in revenue and deliver our first full year of net income profitability.": CEO Andrew Dudum 
Via Investor's Business Daily
Forecasting The Future: 5 Analyst Projections For Doximity
Via Benzinga
2 Beaten-Down Stocks to Buy and Hold for 10 Years
One is a longtime healthcare leader, the other a newcomer; both have bright futures despite recent obstacles. 
Via The Motley Fool
1 Cash-Gushing Stock Down 70% to Buy and Hold Forever
This healthcare upstart, with a free-cash-flow margin of 27% even after removing stock-based compensation, deserves a long look from investors. 
Via The Motley Fool
Is NYSE:DOCS on the Verge of a Major Breakout as a Strong Growth Stock?
DOXIMITY INC-CLASS A (NYSE:DOCS)—Positioned as a High-Growth Stock, Ready for a Potential Breakout. 
Via Chartmill
What's Going With Medical Professionals-Networking Service Doximity Stock Today?
Doximity exceeds Q3 2024 expectations with $135.3 million revenue, up 17% YoY. CEO Jeff Tangney highlights double-digit growth, beating adjusted EPS and raising FY2024 outlook. 
Via Benzinga
Recap: Doximity Q3 Earnings
Via Benzinga
Earnings Scheduled For February 8, 2024
Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million. 
Via Benzinga
In the world of growth stocks, NYSE:DOCS shines as a value proposition.
Investors seeking growth at a reasonable cost should explore DOXIMITY INC-CLASS A (NYSE:DOCS). 
Via Chartmill
For those who appreciate growth without the sticker shock, NYSE:DOCS is worth considering.
Don't overlook DOXIMITY INC-CLASS A (NYSE:DOCS)—a stock with solid growth prospects and a reasonable valuation. 
Via Chartmill
3 Stocks to Capitalize on the Telehealth Explosion
These three telehealth stocks are leading the way for improved telehealth offerings, highlighted after the pandemic. 
Via InvestorPlace
7 Stocks that Multiple AI Bots Predict Will Soar in the Near Future
AI chatbots including ChatGPT and Bard believe these stocks are headed higher in the future, perhaps the near future. 
Via InvestorPlace
Topics Artificial Intelligence
Investors should take note of NYSE:DOCS, a growth stock that remains attractively priced.
DOXIMITY INC-CLASS A (NYSE:DOCS), a growth stock which is not overvalued. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback